McKesson Corporation (0JZU.L)
USD 705.49
(-0.86%)
USD 705.49
(-0.86%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 21.13 Billion USD | 7.35% |
| 2022 | 19.69 Billion USD | 5.29% |
| 2021 | 18.7 Billion USD | -2.83% |
| 2020 | 19.24 Billion USD | 15.01% |
| 2019 | 16.73 Billion USD | 0.15% |
| 2018 | 16.7 Billion USD | 2.45% |
| 2017 | 16.31 Billion USD | 6.75% |
| 2016 | 15.27 Billion USD | -0.37% |
| 2015 | 15.33 Billion USD | 7.27% |
| 2014 | 14.29 Billion USD | 10.09% |
| 2013 | 12.98 Billion USD | 25.65% |
| 2012 | 10.33 Billion USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 25.57 Billion USD | 20.97% |
| 2023 Q1 | 20.51 Billion USD | 4.16% |
| 2023 Q4 | 21.13 Billion USD | -4.0% |
| 2023 Q3 | 22.02 Billion USD | 0.34% |
| 2023 Q2 | 21.94 Billion USD | 7.0% |
| 2023 FY | 21.13 Billion USD | 7.35% |
| 2022 FY | 19.69 Billion USD | 5.29% |
| 2022 Q3 | 20.65 Billion USD | 3.93% |
| 2022 Q2 | 19.87 Billion USD | 1.9% |
| 2022 Q1 | 19.5 Billion USD | 4.29% |
| 2022 Q4 | 19.69 Billion USD | -4.68% |
| 2021 Q2 | 19.34 Billion USD | -3.37% |
| 2021 Q1 | 20.01 Billion USD | 4.0% |
| 2021 FY | 18.7 Billion USD | -2.83% |
| 2021 Q3 | 19.02 Billion USD | -1.64% |
| 2021 Q4 | 18.7 Billion USD | -1.69% |
| 2020 Q2 | 18.43 Billion USD | 11.01% |
| 2020 Q3 | 19.21 Billion USD | 4.21% |
| 2020 Q4 | 19.24 Billion USD | 0.18% |
| 2020 FY | 19.24 Billion USD | 15.01% |
| 2020 Q1 | 16.6 Billion USD | -0.76% |
| 2019 FY | 16.73 Billion USD | 0.15% |
| 2019 Q3 | 17.02 Billion USD | 4.06% |
| 2019 Q4 | 16.73 Billion USD | -1.68% |
| 2019 Q1 | 16.6 Billion USD | -0.63% |
| 2019 Q2 | 16.35 Billion USD | -1.49% |
| 2018 Q3 | 16.95 Billion USD | 1.68% |
| 2018 FY | 16.7 Billion USD | 2.45% |
| 2018 Q1 | 16.36 Billion USD | 0.33% |
| 2018 Q2 | 16.67 Billion USD | 1.88% |
| 2018 Q4 | 16.7 Billion USD | -1.43% |
| 2017 Q3 | 17.1 Billion USD | 1.29% |
| 2017 Q4 | 16.31 Billion USD | -4.64% |
| 2017 FY | 16.31 Billion USD | 6.75% |
| 2017 Q1 | 15.49 Billion USD | 1.44% |
| 2017 Q2 | 16.88 Billion USD | 8.95% |
| 2016 Q1 | 15.5 Billion USD | 1.08% |
| 2016 Q4 | 15.27 Billion USD | -5.23% |
| 2016 Q3 | 16.12 Billion USD | 5.55% |
| 2016 FY | 15.27 Billion USD | -0.37% |
| 2016 Q2 | 15.27 Billion USD | -1.46% |
| 2015 FY | 15.33 Billion USD | 7.27% |
| 2015 Q4 | 15.33 Billion USD | -6.56% |
| 2015 Q3 | 16.41 Billion USD | 5.29% |
| 2015 Q2 | 15.58 Billion USD | 4.39% |
| 2015 Q1 | 14.93 Billion USD | 4.45% |
| 2014 Q1 | 14.12 Billion USD | 8.76% |
| 2014 Q4 | 14.29 Billion USD | -7.04% |
| 2014 Q3 | 15.37 Billion USD | 9.35% |
| 2014 Q2 | 14.06 Billion USD | -0.43% |
| 2014 FY | 14.29 Billion USD | 10.09% |
| 2013 Q1 | 10.33 Billion USD | -0.03% |
| 2013 Q2 | 10.48 Billion USD | 1.47% |
| 2013 Q3 | 11.46 Billion USD | 9.33% |
| 2013 Q4 | 12.98 Billion USD | 13.3% |
| 2013 FY | 12.98 Billion USD | 25.65% |
| 2012 Q4 | 10.33 Billion USD | -0.53% |
| 2012 Q3 | 10.39 Billion USD | 0.0% |
| 2012 FY | 10.33 Billion USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -15182.236% |
| Align Technology, Inc. | 296.9 Million USD | -7019.858% |
| Elevance Health Inc. | -46.33 Billion USD | 145.625% |
| AxoGen, Inc. | 23.02 Million USD | -91728.844% |
| Boston Scientific Corporation | 2.48 Billion USD | -751.006% |
| CVS Health Corporation | 18.02 Billion USD | -17.276% |
| Cardinal Health, Inc. | 14.95 Billion USD | -41.332% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -14671.671% |
| HCA Healthcare, Inc. | 2.02 Billion USD | -945.967% |
| Hologic, Inc. | 679.8 Million USD | -3009.591% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | -5458.77% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | -4354.067% |
| Masimo Corporation | 545 Million USD | -3778.716% |
| Patterson Companies, Inc. | 782.89 Million USD | -2600.096% |
| Quest Diagnostics Incorporated | 190 Million USD | -11025.789% |
| ResMed Inc. | 822.25 Million USD | -2470.873% |
| Henry Schein, Inc. | 1.81 Billion USD | -1064.683% |
| Teladoc Health, Inc. | 29.51 Million USD | -71526.063% |
| Universal Health Services, Inc. | 216.98 Million USD | -9642.013% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | -648.548% |
| Becton, Dickinson and Company | 3.27 Billion USD | -545.86% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | -1631.853% |
| Danaher Corporation | 2.59 Billion USD | -714.919% |
| Stryker Corporation | 4.84 Billion USD | -336.486% |
| Medtronic plc | 5.21 Billion USD | -305.195% |